|
|
||||||||
Ann Thorac Surg 2006;82:1519-1521
© 2006 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Hammersmith Hospital, London, United Kingdtom
b Department of Infectious Disease, Hammersmith Hospital, London, United Kingdom
c Department of Histopathology, Hammersmith Hospital, London, United Kingdom
d Department of Immunology & Molecular Pathology, University College London, Windeyer Building, London, United Kingdom
Accepted for publication February 7, 2006.
* Address correspondence to Dr Hornick, Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College, 2nd Floor, B Block, Hammersmith Campus, Du Cane Rd, London, W12 0NN, UK (Email: p.hornick{at}imperial.ac.uk).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A 47-year-old Indian man, who has resided in the United Kingdom for more than 30 years, underwent elective coronary artery bypass grafting (CABG) for ischemic heart disease. He had no past history of TB. At the time of surgery, he had been well with no antecedent symptoms. He had a normal preoperative assessment including chest roentgenogram, full blood count, and renal and liver biochemistry. At operation, no pericardial abnormalities were noted and there was no effusion. He was discharged fit and well on postoperative day 10. During the ensuing 3-month period he presented twice with exertional breathlessness. At these times he was afebrile with no leukocytosis or rise in his C-reactive protein. However, on each occasion, a computed tomographic scan and transthoracic echocardiography revealed a significant pericardial collection that was completely drained using minimally invasive methods providing full symptomatic improvement. Six weeks after discharge, he again presented with a large compromising pericardial effusion. On this occasion, a large pericardial window was fashioned together with insertion of a pericardial drain. Tissue and pericardial fluid specimens were collected for histology, immunohistochemistry, and microbiology.
Despite the absence of any constitutional symptoms, and an anergic 10-unit Mantoux skin test, in view of the recurrent effusions and his ethnicity, the risk of TB was considered to be sufficiently high to warrant empirical anti-TB treatment. Therefore he was started on combination therapy with Rifater (Aventis Pharma, Kent, UK), comprising a daily dose of 720 mg of rifampin, 300 mg of isonaizid and 1.8 g of pyrazinamide, together with 400 mg/day of moxifloxacin (ethambutol not used due to color blindness) and corticosteroids (80 mg prednisolone). This presumptive diagnosis of TB was supported by histologic examination of the resected pericardial tissue, which showed epithelioid cell granuloma with Langhans-type giant cells. The epithelioid granulomas were immunohistochemically positive with a polyclonal antibody specific to mycobacterium TB (anti-MTB polyclonal, Novocastra plc, Newcastle, UK) (Fig 1).
|
| Comment |
|---|
|
|
|---|
In general, TB pericardial effusions are relatively uncommon in developed countries, and there are no reports after pericardiotomy. Sagrista-Sauleda and colleagues [3] studied 322 patients with pericardial effusions for a 6-year period and found TB as a cause in only 2%. Nevertheless, increasing international migration has increased the risks. The incidence of TB has been rising by 25% in England for the last 10 years with 2 in 5 cases found in London and 7 in 10 being from an ethnic minority background [4]. Tuberculous pericarditis usually spreads from the lungs, mediastinal nodes, or bony structures, but can also spread through the hematogenous route. It may sometimes be associated with an effusion. Progression commonly leads to a constrictive pericarditis. The mortality rate in untreated acute effusive tuberculous pericarditis approaches 85% [5].
Identification of Mycobacterium TB in pericardial fluid or tissue, or the presence of caseous granulomas in histologic examination of pericardial tissue establishes the diagnosis [5]. Finding acid-alcohol-fast bacilli (AAFB) within the granuloma is conclusive, but insensitive. In contrast, TB immunohistochemistry is both sensitive and specific [6]. This is probably because antibodies detect not just intact bacilli, but also epitopes that are generated from the processing of killed bacteria. In addition, even in isolated broth suspensions of mycobacteria, immunohistochemistry is several fold more sensitive than AAFB [6]. Thus, TB immunohistochemistry may differentiate between TB and other causes of epitheloid cell granulomas (eg, sarcoidosis). Our TB immunohistochemistry was confirmed by positive control tissue that confirmed the antibodies were positively stained identifiable bacilli in addition to more diffuse staining of the granuloma macrophages.
Once diagnosed with TB, patients are treated with anti-TB therapy for a period of 6 months. Controversy remains regarding the use of steroids in TB pericarditis. Nevertheless, systematic review of the literature, especially trial data from South Africa, indicates that they may have a role in nonresolving effusions [7].
Cardiopulmonary bypass [8] and surgery are known to be immunosuppressive. We postulate that this immunosuppression led to reactivation of tubercular pericarditis causing large recurrent pericardial effusions until appropriate anti-TB treatment was initiated.
A high index of suspicion and early investigation is required in recurrent pericardial effusions after cardiac surgery, especially in immigrant populations. Although immunohistochemistry is a very sensitive and novel mode of diagnosis, treatment with anti-TB drugs and steroids may need to be started empirically and will help to prevent long-term complications.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. W. Khalil and P. K. Sarkar Tuberculous Pericarditis After Coronary Artery Bypass Graft Ann. Thorac. Surg., September 1, 2007; 84(3): 1074 - 1074. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |